Delfa

AI-powered patient recruitment for clinical trials

London, United Kingdom · $3.8M raised

Headquarters
London
Employees
1–10
Business Model
B2B
Website
delfa.ai
Total Funding
$3.8M
Last Round
$3.8M SeedAug 2025
Rounds
1

About

Delfa is an AI-native operating system for clinical trials, focused on automating patient recruitment for clinical research sites. The platform deploys AI agents that conduct multilingual outreach via phone, SMS, and chat to prescreen patients for medical eligibility, answer questions, collect medical histories, schedule visits, and write directly into a site's CRM or CTMS. Founded by CEO Tom Farrand and CTO Gustav Bredell, Delfa raised a $3.8M seed round led by Air Street Capital and is live across 50+ trials, helping site networks like Flourish, Elevate, and Re:Cognition accelerate enrollment and reduce recruiter workload.

Summary

Delfa is an Artificial Intelligence company based in London, United Kingdom. It has raised $3.8M in total across 1 round, most recently a $3.8M Seed round in Aug 2025. Investors include Air Street Capital, Entrepreneur First and Transpose Platform Management.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundAug 2025
$3.8M

Investors

Similar Companies